REGENXBIO Inc.
Current role
RGNX
Stephen Pakola
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Pakola
The proxy statement of REGENXBIO Inc. reports total compensation of $1,799,546 for Stephen Pakola in fiscal 2025, including a base salary of $543,987. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
REGENXBIO Inc. (RGNX)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- Kenneth T. Mills Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | REGENXBIO Inc. (RGNX) | EVP, Chief Medical Officer | $543,987 | $1,799,546 |
| 2024 | REGENXBIO Inc. (RGNX) | EVP, Chief Medical Officer | $518,082 | $2,696,858 |
| 2023 | REGENXBIO Inc. (RGNX) | EVP, Chief Medical Officer | $498,156 | $3,305,985 |
| 2022 | REGENXBIO Inc. (RGNX) | EVP, Chief Medical Officer | $478,996 | $1,854,615 |
Recent activity
No call appearances or filed executive changes recorded yet.